Skip to main content
. 2018 Aug 9;13(8):e0200953. doi: 10.1371/journal.pone.0200953

Table 1. Performance on ACCT subtests in ALS patients and healthy subjects. Data are expressed as Means (SD).

ALS patients
N = 21
Healthy controls
N = 21

Mean (SD) Mean (SD) W/Z p-value
ACCT-1 mean latency 3.804 (0.798) 3.253 (0.452) 317 .015
ACCT-2 mean latency 4.288 (0.970) 3.647 (0.657) 312 .021
ACCT-3 mean latency 4.356 (0.826) 3.976 (0.770) 287 .1
ACCT-4 mean latency 4.282 (1.088) 3.503 (0.650) 318 .014
ACCT-1 sd latency 1.215 (1.680) 0.538 (0.403) 311 .023
ACCT-2 sd latency 1.204 (0.790) 0.798 (0.568) 292 .07
ACCT-3 sd latency 1.167 (0.534) 0.855 (0.366) 293 .07
ACCT-4 sd latency 1.617 (1.156) 0.855 (0.523) 313 .020
ACCT-1 n° correct 11.81 (0.51) 11.90 (0.30) -0.515 .7
ACCT-2 n° correct 10.86 (2.65) 11.71 (0.46) -1.417 .2
ACCT-3 n° correct 10.62 (2.50) 11.57 (0.81) -1.685 .1
ACCT-4 n° correct 10.71 (2.72) 11.57 (1.08) -1.838 .07

Bold numbers indicate statistical significance with p < 0.05.

Abbreviations: W = Wilcoxon; Z = exact Wilcoxon Mann-Whitney test; sd latency = mean latency standard deviation; n° correct = number of correct responses.